Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.120
+0.170 (4.30%)
At close: Oct 27, 2026, 4:00 PM EDT
4.120
0.00 (0.00%)
After-hours: Oct 27, 2026, 4:00 PM EDT
Coya Therapeutics Market Cap
Coya Therapeutics has a market cap or net worth of $96.65 million as of October 27, 2026. It is the 25,625th most valuable company in the world and the 4,138th biggest in the United States. Its market cap has decreased by 8.28% in one year.
Market Cap
96.65M
Enterprise Value
53.47M
1-Year Change
-8.28%
Global Rank
Country Rank
#4,138 United States
Category
ChartMarket Cap Chart
Since the IPO on December 29, 2022, Coya Therapeutics's market cap has increased from $11.84M to $96.65M, an increase of 716.46%. That is a compound annual growth rate of 73.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 96.65M | -20.37% |
| Dec 31, 2025 | 121.36M | 26.77% |
| Dec 31, 2024 | 95.73M | -10.29% |
| Dec 29, 2023 | 106.71M | 769.50% |
| Dec 30, 2022 | 12.27M | 3.68% |
| Dec 29, 2022 | 11.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PMV Pharmaceuticals | 95.90M |
| ImmuCell | 93.09M |
| NeurAxis | 92.93M |
| Inovio Pharmaceuticals | 92.76M |
| Polaryx Therapeutics | 92.22M |
| Milestone Pharmaceuticals | 91.34M |
| Genelux | 89.62M |
| Tonix Pharmaceuticals Holding | 88.67M |